Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Sunday, June 18 • 1:00pm - 4:30pm
#35: Digital Health Technologies for Combination Products and Beyond: Development and Regulation

Sign up or log in to save this to your schedule and see who's attending!

Feedback form is now closed.
Component Type: Tutorial
CE: CME 3.25; IACET 3.25; RN 3.25

This short course will focus on how digital health technologies are being developed and regulated in the pharmaceutical/combination products space. Although many digital health technologies follow a fairly straightforward regulatory path as devices, those that interact with drug products often encounter more regulatory uncertainty. FDA’s policy on how mobile medical apps, clinical decision support software, and wearables can be combined with pharmaceutical use is still in development, so it is often difficult to navigate the regulatory path to market for these products. This course will look at currently available FDA guidances and what they mean for digital health products that combine both a drug and device. Participants will explore how to work with FDA when developing digital health technologies that may veer outside of established regulatory pathways, and a series of case studies will examine how innovators have addressed development and regulatory hurdles.

Learning Objectives

Describe how digital health technologies are being regulated by FDA through a discussion of current FDA guidances and their effect on the development and approval of digital health products, some of which combine both a drug and device; Identify how to work with FDA when developing digital health technologies via established regulatory pathways and what to do when those technologies veer outside of established regulatory pathways.


Speakers
avatar for Wade Ackerman

Wade Ackerman

Partner, Covington & Burling LLP
Wade Ackerman is a partner in Covington’s Food, Drug, and Device practice. Until June 2016, Mr. Ackerman served as Senior FDA Counsel to the U.S. Senate Health Education, Labor & Pensions Committee where he was involved in legislative initiatives, oversight hearings, and other... Read More →


Sunday June 18, 2017 1:00pm - 4:30pm
S404a McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  • format json
  • Featured Topics Devices-Combination Products
  • Credit Type CME, IACET, RN
  • Tags Tutorial